Table 1 National infectious disease screening recommendations for asylum seekers

Pulmonary tuberculosis

All

Tuberculosis (TB) incidence 50/100000 or above in the country of origin, or originating from conflict areas, or having lived in camp settings, or close contacts to TB patients, or symptoms of TB

Chest X-ray from two^a projections (CXR)

Latent extra-pulmonary tuberculosis

BCG-unvaccinated children under 7 years of age

Tuberculosis (TB) incidence 50/100000 or above in the country of origin, or originating from conflict areas, or having lived in camp settings, or close contacts to TB, or symptoms of TB

Interferon Gamma Realease Assay (IGRA)

Hepatitis B

All

HBsAg prevalence above 2% in the country of origin or transit

Serum Hepatitis B surface antigen (HBsAg)

HIV

All

HIV prevalence above 1% in the country of origin or transit, or specific risk behavior such as injecting drug use, sex between men, incarceration, commercial sex work, or an individuals own request

Serum Human Immunodeficiency Virus antigen and antibodies (HIVAgAb)

Syphilis

All

If HBsAG or HIVAgAb screening is performed

Serum Treponema pallidum antibodies (anti-Trpa)

Intestinal parasites

Children under 16 years of age

Country of origin or transit in South-East Asia, India or Sub-Saharan Africa

Direct microscopy of fecal parasites